Daniela Bota, MD of UC Irvine Health gives an overview of the final results of the TAVAREC trial, which studied temozolomide and bevacizumab in patients with glioma. This was recorded at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.
Abstract 2009: Final Results of the EORTC Brain Tumor Group Randomized Phase II TAVERAC Trial on Temozolomide with or without Bevacizumab in 1st Recurrance Grade II/III Glioma without 1p/19q co-deletion
Advertisement